Literature DB >> 6306978

Neuropathy accompanying IgM lambda monoclonal gammopathy.

K Stefansson, L Marton, J P Antel, R L Wollmann, R P Roos, G Chejfec, B G Arnason.   

Abstract

A set of observations made on a patient with IgM lambda monoclonal gammopathy and neuropathy implicate humoral immunity in the pathogenesis of the neuropathy. A sural nerve biopsy from the patient showed a characteristic increase in the width of the intraperiod lines. Deposits of mu-heavy chains and lambda-light chains were found in myelin sheaths of the nerve biopsy. Immunohistochemically, it was demonstrated that mu-heavy chains and lambda-light chains from the patient's serum bound to myelin sheaths of normal peripheral nerves and to a lesser extent to myelin sheaths in the central nervous system (CNS). By immunoblots it was demonstrated that mu-heavy chains and lambda-light chains from the patient's serum bound to myelin associated glycoprotein but to no other antigens from the peripheral and central nervous systems. gamma and alpha heavy chains and chi light chains from the patient's serum were also shown to bind to myelin-associated glycoprotein but not as distinctly as the mu and lambda chains. It is postulated that the monoclonal gammopathy may have arisen on the background of polyclonal autoimmune attack directed against myelin-associated glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306978     DOI: 10.1007/bf00691490

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  The initial structural lesion in serum-induced demyelination in vitro.

Authors:  M B Bornstein; C S Raines
Journal:  Lab Invest       Date:  1976-10       Impact factor: 5.662

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  Fine structural aspects of demyelination in vitro. The effects of Guillain-Barré serum.

Authors:  A Hirano; S D Cook; J N Whitaker; P C Dowling; M R Murray
Journal:  J Neuropathol Exp Neurol       Date:  1971-04       Impact factor: 3.685

4.  Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain.

Authors:  S Sato; R H Quarles; R O Brady
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

5.  Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin.

Authors:  N Latov; W H Sherman; R Nemni; G Galassi; J S Shyong; A S Penn; L Chess; M R Olarte; L P Rowland; E F Osserman
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

6.  Myelin-associated glycoprotein demonstrated immunocytochemically in myelin and myelin-forming cells of developing rat.

Authors:  N H Sternberger; R H Quarles; Y Itoyama; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  The plasma cell dyscrasias: diverse presentations, pathophysiology, and management.

Authors:  E R Eichner
Journal:  Postgrad Med       Date:  1980-06       Impact factor: 3.840

8.  Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures.

Authors:  C S Raine; M B Bornstein
Journal:  Lab Invest       Date:  1979-04       Impact factor: 5.662

9.  Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy.

Authors:  P E Braun; D E Frail; N Latov
Journal:  J Neurochem       Date:  1982-11       Impact factor: 5.372

10.  Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin.

Authors:  B D Trapp; R H Quarles
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539

View more
  16 in total

Review 1.  Relationship between autoantibody specificities and peripheral nervous system involvements.

Authors:  M O Jauberteau-Marchan
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Monoclonal antibodies to myelin-associated glycoprotein reveal antigenic structures and suggest pathogenic mechanisms.

Authors:  A J Steck; N Murray
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Two large glycosylated polypeptides found in myelinating oligodendrocytes but not in myelin.

Authors:  J R Gulcher; L S Marton; K Stefansson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses.

Authors:  S Nitayaphan; M M Toth; R P Roos
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

Review 5.  Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.

Authors:  Michael Pt Lunn; Eduardo Nobile-Orazio
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04

Review 6.  Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?

Authors:  H J Willison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

7.  Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis.

Authors:  C Meier; K Roberts; A Steck; C Hess; E Miloni; L Tschopp
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Pattern of reactivity of IgM from the sera of eight patients with IgM monoclonal gammopathy and neuropathy with components of neural tissues: evidence for interaction with more than one epitope.

Authors:  F Lieberman; L S Marton; K Stefansson
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

9.  Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins.

Authors:  A A Ilyas; R H Quarles; M C Dalakas; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Passive transfer studies in demyelinating neuropathy with IgM monoclonal antibodies to myelin-associated glycoprotein.

Authors:  A J Steck; N Murray; J C Justafre; C Meier; K V Toyka; K Heininger; G Stoll
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.